Assessing the incidence, epidemiological description and associated risk factors of breast cancer in western Amhara, Ethiopia

IF 0.4 Q4 ONCOLOGY Breast Cancer Management Pub Date : 2020-08-21 DOI:10.2217/bmt-2020-0024

L. M. Tesfaw, Teshome A Teshale, E. K. Muluneh

引用次数: 1

Abstract

Aim: This study aimed at assessing the incidence, epidemiological description and associated risk factors of breast cancer in western Amhara, Ethiopia. Patients & methods: A total of 128 breast cancer patients being treated at Feleget Hiwot Referral Hospital (Bahir Dar, Ethiopia) were subjects of the study. Investigators controlled data quality and employed the ordinal logistic regression model to identify the effect of factors. Results: Of the 128 breast cancer patients under study, 119 (93%) were females. Most of the patients, 67 (52.34%), had advanced stage (IV) cancer that reduced their chance to recover after treatment. Conclusion: Patients who received chemotherapy and surgery for breast cancer were likely to improve than patients who received only chemotherapy. As the stage of breast cancer increased, the likelihood of the patient’s status to be improved decreases. Patients from rural areas, where healthcare services are rarely available, were less likely to recover or improve as compared with those from urban areas.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

评估埃塞俄比亚阿姆哈拉西部地区乳腺癌的发病率、流行病学描述和相关危险因素

目的:本研究旨在评估埃塞俄比亚西部阿姆哈拉地区乳腺癌的发病率、流行病学描述及相关危险因素。患者和方法:共有128名在Feleget Hiwot转诊医院(Bahir Dar，埃塞俄比亚)接受治疗的乳腺癌患者作为研究对象。研究者控制数据质量，采用有序逻辑回归模型确定影响因素。结果:128例乳腺癌患者中，119例(93%)为女性。大多数患者，67例(52.34%)为晚期(IV)癌，治疗后恢复的机会减少。结论:接受化疗和手术治疗的乳腺癌患者比只接受化疗的患者更有可能改善病情。随着乳腺癌分期的增加，患者病情得到改善的可能性降低。农村地区的病人很少获得保健服务，与城市地区的病人相比，农村地区的病人康复或好转的可能性较小。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Breast Cancer Management ONCOLOGY-

CiteScore

0.60

自引率

0.00%

发文量

审稿时长

13 weeks

期刊介绍： Breast Cancer Management (ISSN: 1758-1923) addresses key issues in disease management by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal also highlights significant advances in basic and translational research, and places them in context for future therapy. Breast Cancer Management provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease. Recent research findings and advances clinical practice in the field are reported and analyzed by international experts. The journal presents this information in clear, accessible formats. All articles are subject to independent review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal’s Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3. Coverage includes: Diagnosis and imaging, Surgical approaches, Radiotherapy, Systemic therapies, Cancer clinical trials, Genetic aspects of disease, Personalized medicine, Translational research and biomarker studies, Management of psychological distress, Epidemiological studies, Pharmacoeconomics, Evidence-based treatment guidelines.